MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs
Go back to MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs| (NASDAQ: INKT) | Delayed: 12.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.25 | 52 Week High | $ | |||
| Open | $12.25 | 52 Week Low | $ | |||
| Day High | $12.25 | P/E | N/A | |||
| Day Low | $12.25 | EPS | $ | |||
| Volume | 99 | |||||
